Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)

NCT02412267 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-cell Lymphoma

Interventions

DRUG: O-ICE (ofatumumab, Ifosfamide, Carboplatin, Etoposide)

Sponsor

National Cancer Centre, Singapore

Collaborators

[object Object]